Bristol-Myers Squibb Company

01/04/2021 | Press release | Distributed by Public on 01/04/2021 06:06

European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer,[...]